We are live on
!
Find out more
QL
Quarry LP Portfolio holdings
AUM
$558M
1-Year Est. Return
23.92%
This Fund
S&P 500
This Quarter
Est. Return
+12.52%
1 Year Est. Return
+23.92%
3 Year Est. Return
+50.42%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$456M
AUM Growth
-$13.9M
(-3%)
Cap. Flow
-$63.7M
Cap. Flow
% of AUM
-13.98%
Top 10 Holdings %
Top 10 Hldgs %
25.47%
Holding
2,596
New
898
Increased
514
Reduced
676
Closed
459
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CYBR
CyberArk
CYBR
|
+$14.1M |
| 2 |
VRNA
Verona Pharma
VRNA
|
+$10.2M |
| 3 |
Norfolk Southern
NSC
|
+$9.23M |
| 4 |
GTLS
Chart Industries
GTLS
|
+$6.24M |
| 5 |
SPR
Spirit AeroSystems
SPR
|
+$5.89M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$22.3M |
| 2 |
CHX
ChampionX
CHX
|
+$15.9M |
| 3 |
ANSS
Ansys
ANSS
|
+$12.3M |
| 4 |
K
Kellanova
K
|
+$10.7M |
| 5 |
BTX
BlackRock Technology and Private Equity Term Trust
BTX
|
+$8.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.79% |
| 2 | Communication Services | 9.99% |
| 3 | Industrials | 9.79% |
| 4 | Technology | 9.29% |
| 5 | Healthcare | 6.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATXS
1601
DELISTED
Astria Therapeutics
ATXS
| $12.5K | ﹤0.01% |
+1,717
| New | +$11.6K |
|
1602
Invesco Mortgage Capital
IVR
$776M
| $12.5K | ﹤0.01% |
1,650
-1,034
| -39% | -$7.89K |
|
1603
Abbott
ABT
$180B
| $12.5K | ﹤0.01% |
93
-249
| -73% | -$32.7K |
|
1604
Myriad Genetics
MYGN
$530M
| $12.3K | ﹤0.01% |
+1,708
| New | +$10.1K |
|
1605
Innovative Solutions & Support
ISSC
$342M
| $12.3K | ﹤0.01% |
+986
| New | +$13.8K |
|
1606
Xometry
XMTR
$4.77B
| $12.3K | ﹤0.01% |
226
+215
| +1,955% | +$9.33K |
|
1607
GATX Corp
GATX
$6.55B
| $12.2K | ﹤0.01% |
70
-150
| -68% | -$24.3K |
|
1608
Lifestance Health
LFST
$4.16B
| $12.2K | ﹤0.01% |
+2,222
| New | +$10.9K |
|
1609
Enpro
NPO
$7.05B
| $12.2K | ﹤0.01% |
54
+50
| +1,250% | +$10.8K |
|
1610
Dave Inc
DAVE
$5.12B
| $12.2K | ﹤0.01% |
+61
| New | +$13.2K |
|
1611
Amneal Pharmaceuticals
AMRX
$5.72B
| $12.1K | ﹤0.01% |
+1,212
| New | +$10.9K |
|
1612
Global Net Lease
GNL
$1.87B
| $12K | ﹤0.01% |
1,481
+526
| +55% | +$4.01K |
|
|
GLIBA
1613
Liberty Capital Corp Series A GCI Group Common Stock
GLIBA
$891M
| $12K | ﹤0.01% |
+320
| New | +$11.4K |
|
|
AAM.WS
1614
DELISTED
AA Mission Acquisition Corp Warrants
AAM.WS
| $12K | ﹤0.01% |
+75,000
| New | +$9.5K |
|
1615
Republic Services
RSG
$66.7B
| $11.9K | ﹤0.01% |
52
-1,197
| -96% | -$281K |
|
1616
Kinross Gold
KGC
$28.5B
| $11.9K | ﹤0.01% |
+480
| New | +$9.23K |
|
1617
Howard Hughes
HHH
$3.93B
| $11.9K | ﹤0.01% |
145
-1,574
| -92% | -$117K |
|
1618
Citi Trends
CTRN
$524M
| $11.9K | ﹤0.01% |
+382
| New | +$12.4K |
|
1619
SPS Commerce
SPSC
$2.25B
| $11.8K | ﹤0.01% |
113
-405
| -78% | -$48.2K |
|
1620
Krispy Kreme
DNUT
$543M
| $11.7K | ﹤0.01% |
+3,030
| New | +$10.4K |
|
1621
UBS Group
UBS
$170B
| $11.7K | ﹤0.01% |
+286
| New | +$11.1K |
|
1622
Alcoa
AA
$11.7B
| $11.6K | ﹤0.01% |
+354
| New | +$11K |
|
1623
Horizon Bancorp
HBNC
$1.03B
| $11.6K | ﹤0.01% |
724
-790
| -52% | -$12.7K |
|
1624
Riskified
RSKD
$672M
| $11.6K | ﹤0.01% |
+2,475
| New | +$12.2K |
|
|
TRTX
1625
TPG RE Finance Trust
TRTX
$666M
| $11.5K | ﹤0.01% |
+1,348
| New | +$11.9K |
|
Similar funds
TCM
CAM
SHIM
CFP
DIM
TAWM
HWM
CCA
Quarry LP's Q3 2025 Portfolio in Review
As of Q3 2025, Quarry LP held 2,596 positions worth $456M, down 3% from $470M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Quarry LP withdrew a net $63.7M in Q3 2025, closing 459 positions and reducing 676 holdings. Its most notable exit was Hess, an estimated $22.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Communication Services and Industrials.
Against the trend, Quarry LP opened a new position in CyberArk worth $15.8M.
- Quarry LP's largest Q3 2025 buy was CyberArk: 32,775 shares worth $15.8M.
- Quarry LP added most to Verona Pharma in Q3 2025, an estimated $10.2M increase.
- Quarry LP's biggest Q3 2025 reduction was Kellanova, cutting an estimated $10.7M.
- Quarry LP fully exited Hess in Q3 2025, selling an estimated $22.3M.
- Quarry LP's ten largest holdings make up 25% of its $456M portfolio in Q3 2025.
- Quarry LP opened 898 new positions and closed 459 in Q3 2025.
- Quarry LP's portfolio value fell 3% quarter-over-quarter to $456M.
Based on Quarry LP's 13F filing for Q3 2025, filed 14 Nov 2025.